Cat.#: ACPP-1523
| Despition | RPE65 Blocking Peptide |
| SIZE | 250 µg |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1763 | Human KCTD15 Protein (AC1763) | 5 µg | inquiry |
| ACPP-1042 | Recombinant Human BACE1 Protein (6×His Tag) (AC1042) | 50 µg | inquiry |
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
| ACPP-1404 | Human p59-Fyn Protein (AC1404) | 2 µg | inquiry |
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
| ACPP-1817 | Human NT 4 Protein (AC1817) | 20 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1002 | Recombinant Human CD147 Protein (Fc Tag) (AC1002) | 50 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.